9
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Management of NSAID-induced Gastrointestinal Lesions

&
Pages 106-118 | Published online: 08 Jul 2009

References

  • Somerville K. W., Hawkey C. J. Non-steroidal anti-inflammatory agents and the gastrointestinal tract. Postgrad Med J 1986; 62: 23–8
  • Kurata J. H., Elashoff J. D., Grossman M I. (editorial). Inadequacy of the literature on the relationship between drugs ulcers and gastrointestinal bleeding. Gastroenterology 1982; 82: 373–82
  • Langman M J S. (progress report). Epidemiological evidence for the association of aspirin and acute gastrointestinal bleeding. Gut 1970; 11: 627–34
  • Somerville K., Faulkner Gail Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462–4
  • Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. New Engl J Med 1974; 290: 1158–62
  • Duggan J. M., Dobson A. J., Johnson H, Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986; 27: 929–33
  • Walt R. P., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986, (i): 489–92
  • Caruso I., Porro G. B. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980; 280: 75–8
  • Lanza F., Royer G., Nelson R. An endoscopic evaluation of the effects of non-steriodal anti-inflammatory drugs on the gastric mucosa. Gastrointestinal Endoscopy 1975; 21: 103–5.
  • Laake K, Kjeldaas L, Borchgrevink C F. Side effects of piroxicam (Feldene). Act Med Scand 1984; 215: 81–83
  • Beemann B. Peptic ulcers induced by piroxicam. Br Med J 1985; 290: 789
  • Husby G., Holme I M, Rugstad H. E., Herland O. B., Giercksky K-E. A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clin Rheumatol 1986; 5: 84–91
  • Turnberg L. A., Ross I. N. Studies of the pH gradient across gastric mucus. Scand J Gastroenterol 1984; 19((suppl 92))48
  • Tasman-Jones C. Gastric mucus — physical properties in cytoprotection. Med J Aust 1985; 142((suppl))55–6
  • Williams S. E., Turnberg L. A. Demonstration of a pH gradient across mucus adherent to rabbit gastric mucosa evidence for a 'mucus-bicarbonate' barrier. Gut 1981; 22: 94–6
  • Allen A., Garner A. Mucus and bicarbonate secretion in stomach and their possible role in mucosal protection. Gut 1980; 21: 249–262
  • Miller T. Protective effects of prostaglandins agains gastric mucosal damage. Am J Physiol 1983; 245: G601–623
  • Aly A., Green K., Johansson C. Prostaglandin Synthesis in the Human Gastrointestinal Mucosa. Scand J Gastroenterol 1987; 22(suppl 127)35–38
  • Kivilaakso E., Fromm D., Silen W. Effect of the acid secretory state on intramural pH of rabbit gastric mucosa. Gastroenterology 1978; 75: 641
  • Rachmilewitz D., Limgumsky M., Fich A., Goldin E., Eliakim A., Karmeli F. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. Gastroenterology 1986; 90: 963–9
  • Redfern J. S., Lee E., Feldman M. Effect of indomethacin on gastric mucosal prostaglandins in humans. Gastroenterology 1987; 92: 969–77
  • Rees W. D. W., Gibbons L. C., Warhurst G., Turnberg L. A. Prostaglandin E2 prevents inhibition of human gastric bicarbonate secretion by taurocholate and aspirin. Gastroenterology 1983; 84: 1282
  • Rainsford K. D. The effects of aspirin and other non-steroid anti-inflammatory/analgesic drugs on the gastrointestinal mucus glycoprotein biosynthesis in vivo: Relationship to ulcerogenic actions. Biochem Pharmacol 1978; 27: 877
  • Grossman M. I., Matsumoto K. K., Lichter R. J. Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 1961; 40: 383–8
  • Lanza F., Umbenhauer E. R., Nelson R. S., Rack M. F., Daurio C. P., White L. A. A double-blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of healthy volunteers. J Rheumatol 1982; 9: 415–9
  • Heller S. R., Fellows I. W., Ogilvie A. L., Atkinson M. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J 1982; 285: 167–8
  • Wilkins W. E., Ridley M. G., Pozniak A. L. Benign stricture of the oesophagus. Role of non-steroidal antiinflammatory drugs. Gut 1984; 25: 478–80
  • Lanza F. L. Endoscopic studies of gastric and duodenal injury after the use of Ibuprofen, Aspirin, and other non-steroid antiinflammatory agents. Amer J Med 1984; 13: 19–24, July
  • Osnes M., Larsen L., Eidsaunet W., Thom E. Effect of diclofenac and naproxen on gastroduodenal mucosa. Clin Pharm and Ther 1979; 26: 3, 399–405
  • Lehtola J., Sipponen P. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa. Scand J Rheumatol 1977; 6: 97–102
  • Chernish S. M., Rosenak B. D., Brunelle R. L., Crabtree R. Comparison of gastrointestinal effects of aspirin and fenoprofen. Arthr and Rheum 1979; 22: 376–483
  • Vakil B. J., Shap P. N., Dalai N. J., Wagholikar U. N., Pispati P. K. Endoscopic study of gastrointestinal injury with non-steroidal antiinflammatory drugs. Curr Med Res Poin 1977; 5(1)38–42
  • Kent T. H., Cardelli R. M., Stamler F. W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Amer J Pathol 1969; 54: 237–45
  • Nagaraj H. S., Sandhu A. S., Cook L. N., Buchino J. J., Groff D. B. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediat Surg 1981; 16(6)1003–7
  • Langman M. J. S., Morgan L., Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347–9
  • Madhok A., Mackenzie A., Lee F. D. Small bowel ulceration in patients receiving nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Quart J Med 1986; 255: 53–8
  • Lange J., Bjarnason I., Levi A. J., Price A. Pathology of iatrogenic ileal strictures due to NSAIDs. Gut 1985; 26: A542
  • Shack M E. Drug induced ulceration and perforation of the small intestine. Arizona Med 1966; 23: 517–523
  • Bjarnason I., Zanelli G., Prouse P., Williams P., Gumpel M. J., Levi A J. Effect on Non-Steroidal Anti-inflammatory Drugs on the Human Small Intestine. Drugs 1986; 32((suppl. 1))35–41
  • Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal antiinflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–7
  • Gustavsson S., Nilsson F. Lethal colorectal bleeding — connection with non-steroidal anti-inflammatory drugs?. Lakartidningen 1982; 79: 2644–5
  • Schwarts H. A. Lower Gastrointestinal side effects of nonsteroidal antiinflammatory drugs. J Rheumatol 1981; 8(6)952–4
  • Rampton D. S., McNeil N. I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1973; 24: 187–9
  • Hobbin E., Champion G. Indomethacin suppositories (letter). J Am Geriatr Sci 1986; 34(4)325
  • Hoftiezer J. W., Silvoso G. R., Burks M., Ivey K. J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; ii: 609–12
  • Lanza F. L., Royer G. L., Nelson R. S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. New Engl J Med 1980; 303(3)136–8.
  • Trondstad R. I., Aadland E., Holler T., Olaussen B. Gastroscopic Findings after Treatment with enteric—coated and plain Naproxen tablets in healthy subjects. Scand J Gastroenterology 1985; 20: 239–42
  • Bugat A., Thompson M. R., Aures D. Gastric mucosal lesions produced by intravenous aspirin in cats. Gastroenterology 1976; 71: 754–9
  • Hansen D. F., Aures D., Grossman M. I. Histamine augments gastric ulceration produced in intravenous aspirin in cats. Gastroenterology 1978; 74: 540–3
  • Thorsen W. B., Western D., Tanaka Y. Aspirin injury to the gastric mucosa. Gastrocamera observations of the effect of pH. Arch Intern Med 1968; 121: 499–506
  • Lanza F. L., Royer G. L., Nelson R. S. Effect of a cimetidine-antacid regimen on the gastric and duodenal mucosal injury seen with aspirin and other nonsteroidal antiinflammatory agents. Gastroenterology 1983; 84: 1224
  • Kauffman G. L., Foley K. T., Grossman M. I. Cimetidine does not inhibit Indomethacin-induced small bowel ulceration in the rat. Proc. of the Society for Experimental Biology and Medicine 1979; 161: 512–4
  • Croker J. R., Cotton P. B., Boyle A. C., Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Annals of the Rheum Dis 1980; 39: 275–8
  • Rachmilewitz D., Polak D., Eliakim R., Stalnikowicz R., Wengrower D., Fich A., Ligumsky M. Cimetidine significantly decreases indomethacin induced gastroduodenal mucosal damage. Gastroenterology 1986; 5(2)1596
  • Berkowitz J. M., Adler S. N., Sharp J. T., Warner C. W. Raniditine protects against gastroduodenal lesions associated with chronic aspirin therapy. Gastroenterology 1986; 90(5)1345
  • Muller P., Dammann H-G, Simon B. Akute Schadigung der Magenschleimhaut durch Acetylsalicylsaure. Drug Res 1986; 36(1)265–8
  • Zoli G., Pasquinelli G., Bonvicini F., Gasbarrini G., Laschi R. S E M. study II: Protective effect of Ranitidine against gastric and duodenal lesions induced by non-steroidal drugs Int. J Tiss Reac 1986; 8(10)71–77
  • Aabakken L., Larsen L., Osnes M. Gastrointestianl side affects of naproxen: Are they reduced by cimetidine tablets or suspensions?. Scand J Gastroenterology 1987; 135(22)59, Suppl
  • Stern A. I., Ward F., Harley G. Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa. Am J Med 1987; 83((3B))83–5
  • Malchow-Møller A. Treatment of peptic ulcer induced by non-steroidal. Anti-inflammatory Drugs. Scand J Gastroenterol 1987; 22(Suppl. 127)87–91
  • Caldwell J. R., Roth S. H., Wu Semble W C E. L., Castell D. O., Heller M. D., Marsch W. H. Sucralfate Treatment of Non-steroidal Antiinflammatory Drug-induced gasrointestinal symptoms and damage. Am J Med 1987; 83((3B))74–82
  • Johansson C., Kollberg B., Nordemar R., Samuelson K., Bergstrom S. Protective Effect of Prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology 1980; 78: 479–83
  • Cohen M. M., McCready D. R., Clark L., Sevelius H. Protection against Aspirin-induced antral and duodenal damage with Enprostil. Gastroenterology 1985; 88: 382–6
  • Konturek S. J., Kwiecien N., Obtulowicz W., Polanski M., Kopp B., Oleksy J. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1983; 24: 89–93
  • Hawkey C. J., Walt R. P. Prostaglandins for peptic ulcer. A promise unfulfilled. Lancet 1980; ii: 1084–6
  • Mellem H., Stave R., Myren J., Osnes M., Hanssen L. E., Mosvold J., Hebnes K. Symptoms in patients with peptic ulcer and hematemesis andlor melena related to the use of non-steroid antiinflammatory drugs. Scand J Gastroenterol 1985; 20: 1246–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.